Mode
Text Size
Log in / Sign up

SARS-CoV-2 Omicron BA.2 infection associated with persistent hormonal changes and symptom resolution in young male studentsYour Hormones After COVID: A Two-Year Journey Reveals Surprising Shifts

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note potential long-term hormonal changes after Omicron BA.2 infection in young males, but interpret cautiously due to study limitations.

This prospective cohort study enrolled 71 young male university students following SARS-CoV-2 Omicron BA.2 infection. The comparator was a 3-month post-infection convalescent reference point, with follow-up extending to 24 months. The primary outcome assessed longitudinal changes in reproductive, thyroid, and adrenal hormones, while secondary outcomes included persistent symptoms.

The study observed that persistent symptoms decreased from 11.3% at 3 months to 4.3% at 24 months. Testosterone levels remained stable throughout the follow-up period, with all P values greater than 0.05. In contrast, prolactin declined progressively from 22.55 ng/mL to 14.73 ng/mL at 24 months. Estradiol decreased at all follow-up points (P < 0.0001), while FSH and TSH showed continuous, progressive increases (P < 0.001).

Thyroid hormones TT4 and FT4 exhibited biphasic fluctuations, and ACTH and cortisol generally declined after 6 months (P < 0.0001). No adverse events, serious adverse events, discontinuations, or specific tolerability data were reported. The study limitations include a small sample size, lack of a concurrent control group, and unreported p-values for several outcomes, which restricts the ability to draw definitive causal conclusions.

These results highlight potential hormonal sequelae following Omicron BA.2 infection in young males. However, the observational design and specific demographic focus mean these findings may not apply to other populations or infection variants. Clinicians should interpret these hormonal shifts cautiously until validated in larger, controlled studies.

Hormones are your body’s master controllers. They regulate energy, mood, metabolism, and sexual health.

When they are off, you feel off. The systems that produce them—often called the hypothalamic-pituitary-adrenal (HPA) and hypothalamic-pituitary-gonadal (HPG) axes—are like a delicate chain of command in your brain and glands.

A major illness like COVID can disrupt this system. But for how long? And what exactly changes? Until now, the long-term picture has been fuzzy.

The Surprising Stability

The biggest finding brings immediate relief.

Testosterone, the hormone most associated with male vitality, did not drop. It remained rock-solid and stable throughout the entire 24-month study. This held true even when other hormones were shifting.

This is crucial news. It directly counters a common fear. For young, otherwise healthy men, the data suggests the core reproductive hormone is resilient.

But Here’s The Twist

While testosterone stood firm, the study revealed a hidden dance happening elsewhere. Other hormones showed significant changes over the two years, all compared to a baseline set at 3 months after infection.

Think of your hormonal system like an orchestra. The lead instrument (testosterone) kept perfect time. But the sections for strings, woodwinds, and brass went through a long period of retuning before harmonizing again.

How The Hormones Moved

Scientists saw clear patterns. The hormone prolactin, which was initially high, steadily decreased over two years, finally settling into the normal range.

Follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH) progressively increased. Stress system hormones like ACTH and cortisol generally declined after the first six months.

The Study Snapshot

Researchers followed 71 young male university students who had confirmed Omicron BA.2 cases. They took blood samples at 3 months (used as a recovery baseline), 6 months, 12 months, and 24 months after infection.

This let them map the hormone journey like checking points on a long road trip.

The most patient-relevant finding is the timeline of recovery. Persistent symptoms, like mild fatigue, were reported by 11.3% of men at 3 months. This dropped to just 4.3% by the two-year mark.

Crucially, the average level for every hormone measured stayed within the broad “normal” range used in clinics. The changes were measurable and significant in a statistical model, but they were often subtle shifts within that normal zone.

This suggests the body isn’t suffering permanent damage. Instead, it’s engaging in a long, careful recalibration.

This is where it gets practical.

The Expert Perspective

The study authors interpret these dynamics as “temporal post-infection patterns rather than definitive endocrine injury.” In plain English, the hormones are on a journey, not broken.

The body’s systems are talking to each other and adjusting over a surprisingly long period. This research provides a map of that journey we didn’t have before.

If you are a young man who had COVID and now feel perfectly fine, this study is very reassuring. Your testosterone is likely stable. There is no evidence here to suggest you need to rush out for broad hormone testing.

But there is a critical catch.

This research does not apply to men who are experiencing ongoing symptoms. It also doesn’t apply to older men, women, or those with pre-existing hormonal conditions.

The study’s key recommendation is for those with persistent issues. If you are still struggling with fatigue, weight changes, or low mood long after COVID, talking to a doctor about targeted hormone evaluation is a sensible step. This data helps doctors know what to look for and when.

Understanding The Limits

This was a study of 71 young, healthy university students. Their experience may not translate to the general population, including older adults or those with other health conditions. The study also cannot prove COVID caused the hormonal changes, only that it observed them after infection.

This research opens a door. It gives scientists a detailed, two-year baseline for how hormones behave after this specific virus. The next steps are to see if these patterns hold true in larger, more diverse groups of people.

It also highlights that “recovery” can be a long, multi-system process. For medicine, the lesson is clear: listening to patients’ lasting symptoms is vital, and targeted testing can be a powerful tool.

The broader journey of understanding Long COVID continues. But for one common worry among young men, this study offers a strong measure of peace.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedMar 2026
View Original Abstract ↓
ObjectiveTo investigate the longitudinal changes and temporal patterns of reproductive, thyroid, and adrenal hormones in young males following SARS-CoV-2 Omicron BA.2 infection, using a 3-month post-infection convalescent reference point.MethodsA prospective cohort of 71 young male university students with confirmed Omicron BA.2 infection was followed for 24 months. Fasting blood samples were collected at 3 (early convalescent reference), 6, 12, and 24 months post-infection. Serum levels of 15 hormones across the hypothalamic-pituitary-gonadal (HPG), thyroid (HPT), and adrenal (HPA) axes were measured. Linear mixed-effects models were utilized to assess longitudinal changes over time. Persistent symptoms were recorded at each visit.ResultsAt the 3-month post-infection convalescent reference point, 8 of 71 participants (11.3%) reported mild persistent symptoms, which decreased to 4.3% by 24 months. Testosterone remained stable throughout the follow-up (all P > 0.05). Relative to the 3-month reference, prolactin declined progressively from an initially elevated mean of 22.55 ng/mL to 14.73 ng/mL at 24 months, gradually normalizing within the clinical reference range (4.04–15.2 ng/mL). Estradiol decreased at all follow-up points (P < 0.0001), while FSH and TSH demonstrated continuous, progressive increases (P < 0.001). TT4 and FT4 showed biphasic fluctuations. Adrenal markers (ACTH, cortisol) generally declined after 6 months (P < 0.0001). Ultimately, most mean hormone values remained within normal clinical reference ranges.ConclusionAmong young males, testosterone remained robustly stable over two years following Omicron BA.2 infection, while other endocrine markers displayed measurable longitudinal dynamics relative to the 3-month post-infection convalescent reference point. These findings highlight temporal post-infection patterns rather than definitive endocrine injury. While routine extensive endocrine screening may not be necessary for asymptomatic young males, targeted evaluation is recommended for individuals with persistent symptoms.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.